Convergent Effects of Resveratrol and PYK2 on Prostate Cells

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Resveratrol (RSV), a polyphenol, shows potential as a chemopreventive and chemotherapeutic agent.
• Mechanisms of RSV action and its effects on non-tumor cells are not fully understood.
• Proline-rich tyrosine kinase 2 (PYK2) acts as a tumor suppressor in prostate cells.

Purpose of the Study:

• To investigate the functional relationship between Resveratrol (RSV) and Proline-rich tyrosine kinase 2 (PYK2) in prostate cells.
• To elucidate how PYK2 influences RSV's biological activity, including its effects on oxidative stress, cell growth, and autophagy.

Main Methods:

• Utilized human non-transformed prostate EPN cells and a tumor-prone counterpart (EPN-PKM) expressing a PYK2 dead-kinase mutant.
• Assessed RSV's effects on reactive oxygen species (ROS) production, cell morphology, growth arrest, autophagy, and apoptosis.
• Employed RNA interference (RNAi) to deplete PYK2 and compare its effects with the PYK2 mutant.

Main Results:

• RSV demonstrated significant biological activity in both cell lines, reducing ROS, inducing reversible growth arrest, and activating autophagy without inducing apoptosis.
• The PYK2 mutant elevated basal ROS and autophagy, modulating RSV's effects: antioxidant effects were stronger in normal cells, while anti-proliferative and pro-autophagic effects were greater in tumor-prone cells.
• PYK2 depletion mimicked the effects of the PYK2 mutant, confirming PYK2's role in mediating RSV's actions.

Conclusions:

• PYK2 and RSV interact within common cellular pathways, suggesting PYK2's potential role in mediating RSV's mechanisms of action in prostate cells.
• The efficacy of RSV in prostate cells may be influenced by the mutational status or expression levels of PYK2.
• The reversible and non-apoptotic nature of RSV effects in tumor-prone cells warrants caution regarding its clinical application in humans.